Bracco to invest $230M in new US contrast media plant, creating 200 jobs
Bracco Diagnostics announced a $230 million investment to build its first U.S. manufacturing facility for injectable contrast media in Sanford, North Carolina.
The plant is slated to create about 200 jobs across manufacturing, engineering, technical operations, quality, warehousing and administration, and will expand the company's production capacity.
By adding sterile manufacturing capacity in its largest market, Bracco aims to improve supply chain resilience and meet growing demand for contrast agents used in diagnostic imaging.
The new site will complement Bracco's existing facilities in Europe, Asia and Canada, positioning it to compete more directly with rivals such as GE HealthCare, Philips and United Imaging Healthcare.
This writeup was produced by pharmadog from original reporting by Fierce Biotech.
Original headline: “Bracco invests $230M in first US diagnostic imaging manufacturing facility”
read at Fierce Biotech ↗
comments(0)
5-min edit window · permanent after that